Acutus Medical appoints Takeo Mukai as CEO; David Roman becomes consultant

Acutus Medical, Inc.

David Roman departed as president and CEO effective Jan 7, 2024; also resigned from board.
Takeo Mukai, formerly CFO, appointed CEO effective Jan 8, 2024, retaining CFO role.
Mukai's base salary increased from $325,000 to $375,000; target bonus raised to 60% of base.
Roman entered consulting agreement at $200/hour through Dec 31, 2024 to assist with transition and strategic options.
Board size set at seven members.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Roman

President and Chief Executive Officer

Acutus Medical, Inc.

Effective: 2024-01-07
Successor: Takeo Mukai
Filed: January 11, 2024, 6:59 PM ET

David Roman was expected to depart from his position as president and chief executive officer of the Company, as part of the Company’s strategic realignment of resources and corporate restructuring, which departure became effective January 7, 2024.

Departed

David Roman

Member of the Board of Directors

Acutus Medical, Inc.

Effective: 2024-01-07
Filed: January 11, 2024, 6:59 PM ET

Mr. Roman has also resigned as a member of the Company’s board of directors effective January 7, 2023.

Appointed

Takeo Mukai

Chief Executive Officer

Acutus Medical, Inc.

Effective: 2024-01-08
Filed: January 11, 2024, 6:59 PM ET

the Company’s board of directors approved the appointment of Takeo Mukai, the Company’s chief financial officer, as the Company’s chief executive officer, which appointment became effective January 8, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Roman departed as President and Chief Executive Officer at Acutus Medical, Inc..

Action: departed
Role: President and Chief Executive Officer

Exact text from the filing

David Roman was expected to depart from his position as president and chief executive officer of the Company, as part of the Company’s strategic realignment of resources and corporate restructuring, which departure became effective January 7, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

David Roman resigned as Member of the Board of Directors at Acutus Medical, Inc..

Action: resigned
Role: Member of the Board of Directors

Exact text from the filing

Mr. Roman has also resigned as a member of the Company’s board of directors effective January 7, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Takeo Mukai was appointed as Chief Executive Officer at Acutus Medical, Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

the Company’s board of directors approved the appointment of Takeo Mukai, the Company’s chief financial officer, as the Company’s chief executive officer, which appointment became effective January 8, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001628280-24-001153

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.